FDA’s 2016 Guidance Plans Include LDTs and Other Diagnostics Topics
In a series of three recent FDA Voice blog articles, the U.S. Food and Drug Administration (FDA) surveyed its accomplishments in 2015 and detailed its 2016 agenda. The FDA also separately issued its annual list of guidance documents that it plans to finalize in 2016. Both of these releases address issues of importance for clinical […]
This content is exclusive to Lab Compliance Advisor subscribers
Start a Free Trial for immediate access to this article and our entire archive of over 20 years of LCA reports.